| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13549* | 2021 |
| Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing C Kanellopoulou, SA Muljo, AL Kung, S Ganesan, R Drapkin, T Jenuwein, ... Genes & development 19 (4), 489-501, 2005 | 1615 | 2005 |
| Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway I Garcia-Higuera, T Taniguchi, S Ganesan, MS Meyn, C Timmers, J Hejna, ... Molecular cell 7 (2), 249-262, 2001 | 1452 | 2001 |
| Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145-1153, 2010 | 1280 | 2010 |
| 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers P Bouwman, A Aly, JM Escandell, M Pieterse, J Bartkova, ... Nature structural & molecular biology 17 (6), 688-695, 2010 | 1099 | 2010 |
| Carcinoma-associated fibroblast–like differentiation of human mesenchymal stem cells PJ Mishra, PJ Mishra, R Humeniuk, DJ Medina, G Alexe, JP Mesirov, ... Cancer research 68 (11), 4331-4339, 2008 | 1088 | 2008 |
| X chromosomal abnormalities in basal-like human breast cancer AL Richardson, ZC Wang, A De Nicolo, X Lu, M Brown, A Miron, X Liao, ... Cancer cell 9 (2), 121-132, 2006 | 962 | 2006 |
| BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function SB Cantor, DW Bell, S Ganesan, EM Kass, R Drapkin, S Grossman, ... Cell 105 (1), 149-160, 2001 | 872 | 2001 |
| Automatic detection of invasive ductal carcinoma in whole slide images with convolutional neural networks A Cruz-Roa, A Basavanhally, F González, H Gilmore, M Feldman, ... Medical Imaging 2014: Digital Pathology 9041, 904103, 2014 | 749 | 2014 |
| Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent A Cruz-Roa, H Gilmore, A Basavanhally, M Feldman, S Ganesan, ... Scientific reports 7 (1), 46450, 2017 | 559 | 2017 |
| Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1-Mutated Mouse Mammary Tumors JE Jaspers, A Kersbergen, U Boon, W Sol, L Van Deemter, SA Zander, ... Cancer discovery 3 (1), 68-81, 2013 | 555 | 2013 |
| The telomerase reverse transcriptase regulates chromatin state and DNA damage responses K Masutomi, R Possemato, JMY Wong, JL Currier, Z Tothova, JB Manola, ... Proceedings of the national academy of sciences 102 (23), 8222-8227, 2005 | 498 | 2005 |
| Genetic analysis of BRCA1 function in a defined tumor cell line R Scully, S Ganesan, K Vlasakova, J Chen, M Socolovsky, DM Livingston Molecular cell 4 (6), 1093-1099, 1999 | 449 | 1999 |
| BRCA1 supports XIST RNA concentration on the inactive X chromosome S Ganesan, DP Silver, RA Greenberg, D Avni, R Drapkin, A Miron, ... Cell 111 (3), 393-405, 2002 | 382 | 2002 |
| Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer JM Mehnert, A Panda, H Zhong, K Hirshfield, S Damare, K Lane, L Sokol, ... The Journal of clinical investigation 126 (6), 2334-2340, 2016 | 377 | 2016 |
| Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation KK Wong, S Chang, SR Weiler, S Ganesan, J Chaudhuri, C Zhu, ... Nature genetics 26 (1), 85-88, 2000 | 373 | 2000 |
| Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns AR Brannon, A Reddy, M Seiler, A Arreola, DT Moore, RS Pruthi, ... Genes & cancer 1 (2), 152-163, 2010 | 361 | 2010 |
| Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, M0 … INCS Group, VI Trial International Journal of Radiation Oncology* Biology* Physics 35 (3), 463-469, 1996 | 357 | 1996 |
| Computerized image-based detection and grading of lymphocytic infiltration in HER2+ breast cancer histopathology AN Basavanhally, S Ganesan, S Agner, JP Monaco, MD Feldman, ... IEEE Transactions on biomedical engineering 57 (3), 642-653, 2009 | 343 | 2009 |
| Understanding and overcoming resistance to PARP inhibitors in cancer therapy MP Dias, SC Moser, S Ganesan, J Jonkers Nature reviews Clinical oncology 18 (12), 773-791, 2021 | 336 | 2021 |
